Tumor necrosis factor-alpha-nuclear factor-kappa B-signaling enhances St2b2 expression during 12-O-tetradecanoylphorbol-13-acetate-induced epidermal hyperplasia

Biological and Pharmaceutical Bulletin

Volumn 34, Issue 2, 2011, Pages 183-190

  Matsuda, Toshihiro ^a   Shimada, Miki ^a,c   Sato, Akira ^a   Akase, Takanori ^a   Yoshinari, Kouichi ^a   Nagata, Kiyoshi ^a,b   Yamazoe, Yasushi ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^c TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Cholesterol sulfate; Epidermal differentiation; Nuclear factor kappa B; Phorbol ester; Sulfotransferase; Tumor necrosis factor alpha

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; CHOLESTEROL SULFATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INVOLUCRIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN ST2B2; SHORT HAIRPIN RNA; SULFOTRANSFERASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; EPIDERMIS CELL; EPIDERMIS HYPERPLASIA; FEMALE; INFLAMMATION; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODIES; CHOLESTEROL ESTERS; EPIDERMIS; FEMALE; HYPERPLASIA; INFLAMMATION; MICE; MICE, INBRED STRAINS; NF-KAPPA B; NITRILES; PROTEIN PRECURSORS; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; SULFONES; SULFOTRANSFERASES; TETRADECANOYLPHORBOL ACETATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79551477519     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.34.183     Document Type: Article

References (34)

1. Ekanayake-Mudiyanselage S., Aschauer H., Schmook F. P., Jensen J. M., Meingassner J. G., Proksch E., J. Invest. Dermatol., 111, 517-523 (1998).
2. Greenberg C. S., Birckbichler P. J., Rice R. H., FASEB J., 5, 3071-3077 (1991).
3. Takigawa M., Verma A. K., Simsiman R. C., Boutwell R. K., Biochem. Biophys. Res. Commun., 105, 969-976 (1982).
4. Castagna M., Takai Y., Kaibuchi K., Sano K., Kikkawa U., Nishizuka Y., J. Biol. Chem., 257, 7847-7851 (1982).
5. Kikkawa U., Takai Y., Tanaka Y., Miyake R., Nishizuka Y., J. Biol. Chem., 258, 11442-11445 (1983).
6. Nakadate T., Jpn. J. Pharmacol., 49, 1-9 (1989).
7. Elias P. M., Williams M. L., Maloney M. E., Bonifas J. A., Brown B. E., Grayson S., Epstein E. H. Jr., J. Clin. Invest., 74, 1414-1421 (1984).
8. Koppe G., Marinkovic-Ilsen A., Rijken Y., De Groot W. P., Jobsis A. C., Arch. Dis. Child., 53, 803-806 (1978).
9. Zettersten E., Man M. Q., Sato J., Denda M., Farrell A., Ghadially R., Williams M. L., Feingold K. R., Elias P. M., J. Invest. Dermatol., 111, 784-790 (1998).
10. Shimada M., Kamiyama Y., Sato A., Honma W., Nagata K., Yamazoe Y., J. Biochem., 131, 167-169 (2002).
11. Shimada M., Matsuda T., Sato A., Akase T., Matsubara T., Nagata K., Yamazoe Y., Xenobiotica, 38, 1487-1499 (2008).
12. Jetten A. M., George M. A., Pettit G. R., Herald C. L., Rearick J. I., J. Invest. Dermatol., 93, 108-115 (1989).
13. Kiguchi K., Kagehara M., Higo R., Iwamori M., DiGiovanni J., J. Invest. Dermatol., 111, 973-981 (1998).
14. Djian P., Phillips M., Easley K., Huang E., Simon M., Rice R. H., Green H., Mol. Biol. Evol., 10, 1136-1149 (1993).
15. Eckert R. L., Yaffe M. B., Crish J. F., Murthy S., Rorke E. A., Welter J. F., J. Invest. Dermatol., 100, 613-617 (1993).
16. Crish J. F., Howard J. M., Zaim T. M., Murthy S., Eckert R. L., Differentiation, 53, 191-200 (1993).
17. Watt F. M., J. Invest. Dermatol., 81, 100s-103s (1983).
18. Kohler H. B., Huchzermeyer B., Martin M., De Bruin A., Meier B., Nolte I., Vet. Dermatol., 12, 129-137 (2001).
19. Sen C. K., Packer L., FASEB J., 10, 709-720 (1996).
20. Murakawa M., Yamaoka K., Tanaka Y., Fukuda Y., Biochem. Pharmacol., 71, 1331-1336 (2006).
21. Scott K. A., Moore R. J., Arnott C. H., East N., Thompson R. G., Scallon B. J., Shealy D. J., Balkwill F. R., Mol. Cancer Ther., 2, 445-451 (2003).
22. Yamamoto S., Jiang H., Kato R., Carcinogenesis, 12, 1145-1147 (1991).
23. Bradford M. M., Anal. Biochem., 72, 248-254 (1976).
24. Xu X. X., Lambeth J. D., J. Biol. Chem., 264, 7222-7227 (1989).
25. Chen G., Goeddel D. V., Science, 296, 1634-1635 (2002).
26. Dlugosz A. A., Mischak H., Mushinski J. F., Yuspa S. H., Mol. Carcinog., 5, 286-292 (1992).
27. Ohba M., Ishino K., Kashiwagi M., Kawabe S., Chida K., Huh N. H., Kuroki T., Mol. Cell. Biol., 18, 5199-5207 (1998).
28. Osada S., Mizuno K., Saido T. C., Akita Y., Suzuki K., Kuroki T., Ohno S., J. Biol. Chem., 265, 22434-22440 (1990).
29. Zhang G., Kazanietz M. G., Blumberg P. M., Hurley J. H., Cell, 81, 917-924 (1995).
30. Chida K., Murakami A., Tagawa T., Ikuta T., Kuroki T., Cancer Res., 55, 4865-4869 (1995).
31. Fischer S. M., Gleason G. L., Mills G. D., Slaga T. J., Cancer Lett., 10, 343-350 (1980).
32. Amigo M., Paya M., Braza-Boils A., De Rosa S., Terencio M. C., Life Sci., 82, 256-264 (2008).
33. Lizzul P. F., Aphale A., Malaviya R., Sun Y., Masud S., Dombrovskiy V., Gottlieb A. B., J. Invest. Dermatol., 124, 1275-1283 (2005).
34. Seitz C. S., Lin Q., Deng H., Khavari P. A., Proc. Natl. Acad. Sci. U.S.A., 95, 2307-2312 (1998).